Schonfeld Strategic Advisors LLC Entera Bio Ltd. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 599,156 shares of ENTX stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
599,156
Previous 632,311
5.24%
Holding current value
$1.18 Million
Previous $1.32 Million
22.59%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ENTX
# of Institutions
21Shares Held
10.1MCall Options Held
31KPut Options Held
100-
Knoll Capital Management, LLC Miami, FL5.88MShares$11.6 Million6.68% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.7MShares$5.31 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT440KShares$866,0750.1% of portfolio
-
Northern Trust Corp Chicago, IL199KShares$391,6970.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.3KShares$124,7010.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $56.8M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...